Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Other Non Operating Income (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Other Non Operating Income for 2 consecutive years, with $267000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Other Non Operating Income fell 87.59% to $267000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $3.1 million, a 31.35% decrease, with the full-year FY2024 number at $289000.0, up 210.75% from a year prior.
  • Other Non Operating Income was $267000.0 for Q4 2023 at LENZ Therapeutics, down from $3.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.0 million in Q3 2023 to a low of -$54000.0 in Q1 2023.